4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 02-2021 | 12-2020 | 02-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,938 | -30,495 | -30,495 | N/A | -30,333 |
| Depreciation Amortization | 1,472 | 1,572 | 1,572 | N/A | 1,644 |
| Accounts payable and accrued liabilities | -2,866 | 2,677 | 2,677 | N/A | -903 |
| Other Working Capital | -7,212 | 1,309 | 1,309 | N/A | 2,559 |
| Other Operating Activity | 2,628 | -2,333 | -2,333 | 0 | -1,650 |
| Operating Cash Flow | $-37,916 | $-27,270 | $-27,270 | $N/A | $-28,683 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 12,982 |
| PPE Investments | -279 | -211 | -211 | N/A | -626 |
| Purchase Sale Intangibles | N/A | -19 | -19 | N/A | -73 |
| Other Investing Activity | 0 | -19 | -19 | 0 | -73 |
| Investing Cash Flow | $-279 | $-230 | $-230 | $N/A | $12,283 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 24,844 | 36,382 | 36,382 | N/A | N/A |
| Other Financing Activity | 9,074 | -1,915 | -1,915 | 0 | -14 |
| Financing Cash Flow | $46,418 | $34,467 | $34,467 | $N/A | $-14 |
| Exchange Rate Effect | 760 | -8 | -8 | N/A | 1,000 |
| Beginning Cash Position | 11,990 | 5,031 | 5,031 | N/A | 20,445 |
| End Cash Position | 20,973 | 11,990 | 11,990 | N/A | 5,031 |
| Net Cash Flow | $8,983 | $6,959 | $6,959 | $N/A | $-15,414 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,916 | -27,270 | -27,270 | N/A | -28,683 |
| Capital Expenditure | -279 | -211 | -211 | N/A | -681 |
| Free Cash Flow | -38,195 | -27,481 | -27,481 | 0 | -29,364 |